SPRINGWORKS THERAPEUTICS, INC.: cashflow_investing
| Value | {"amount": 34754000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | SPRINGWORKS THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:59:17.328140+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/459e4c9a-be9b-405b-9d65-f51b8d11f065
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001773427-24-000010Retrieved: 2026-08-19T17:59:17.328140+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001773427/cashflow-investing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/459e4c9a-be9b-405b-9d65-f51b8d11f065
History
- no predecessors — first report